Wang Wei, Li Jian, Liu Ransheng, Zhang Aixu, Yuan Zhiyong
Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China.
Department of Radiology, Tianjin Hospital, Tianjin, People's Republic of China.
Onco Targets Ther. 2016 Mar 14;9:1449-59. doi: 10.2147/OTT.S101874. eCollection 2016.
To predict p53 expression index (p53-EI) based on measurements from computed tomography (CT) for preoperatively assessing pathologies of nodular ground-glass opacities (nGGOs).
Information of 176 cases with nGGOs on high-resolution CT that were pathologically confirmed adenocarcinoma was collected. Diameters, total volumes (TVs), maximum (MAX), average (AVG), and standard deviation (STD) of CT attenuations within nGGOs were measured. p53-EI was evaluated through immunohistochemistry with Image-Pro Plus 6.0. A multiple linear stepwise regression model was established to calculate p53-EI prediction from CT measurements. Receiver-operating characteristic curve analysis was performed to compare the diagnostic performance of variables in differentiating preinvasive adenocarcinoma (PIA), minimally invasive adenocarcinoma (MIA), and invasive adenocarcinoma (IAC).
Diameters, TVs, MAX, AVG, and STD showed significant differences among PIAs, MIAs, and IACs (all P-values <0.001), with only MAX being incapable to differentiate MIAs from IACs (P=0.106). The mean p53-EIs of PIAs, MIAs, and IACs were 3.4±2.0, 7.2±1.9, and 9.8±2.7, with significant intergroup differences (all P-values <0.001). An equation was established by multiple linear regression as: p53-EI prediction =0.001* TVs +0.012* AVG +0.022* STD +9.345, through which p53-EI predictions were calculated to be 4.4%±1.0%, 6.8%±1.3%, and 8.5%±1.4% for PIAs, MIAs, and IACs (Kruskal-Wallis test P<0.001; Tamhane's T2 test: PIA vs MIA P<0.001, MIA vs IAC P<0.001), respectively. Although not significant, p53-EI prediction has a little higher area under the curve (AUC) than the actual one both in differentiating MIAs from PIAs (AUC 0.938 vs 0.914, P=0.263) and in distinguishing IACs from MIAs (AUC 0.812 vs 0.786, P=0.718).
p53-EI prediction of nGGOs obtained from CT measurements allows accurately estimating lesions' pathology and invasiveness preoperatively not only from radiology but also from pathology.
基于计算机断层扫描(CT)测量结果预测p53表达指数(p53-EI),以术前评估结节状磨玻璃影(nGGO)的病变情况。
收集176例经病理证实为腺癌的nGGO患者的高分辨率CT信息。测量nGGO内的直径、总体积(TV)、最大(MAX)、平均(AVG)和CT衰减标准差(STD)。通过免疫组织化学和Image-Pro Plus 6.0评估p53-EI。建立多元线性逐步回归模型,根据CT测量结果计算p53-EI预测值。进行受试者操作特征曲线分析,比较各变量在鉴别原位腺癌(PIA)、微浸润腺癌(MIA)和浸润性腺癌(IAC)方面的诊断性能。
PIA、MIA和IAC之间的直径、TV、MAX、AVG和STD均有显著差异(所有P值<0.001),只有MAX无法区分MIA和IAC(P = 0.106)。PIA、MIA和IAC的平均p53-EI分别为3.4±2.0、7.2±1.9和9.8±2.7,组间差异显著(所有P值<0.001)。通过多元线性回归建立方程:p53-EI预测值 = 0.001×TV + 0.012×AVG + 0.022×STD + 9.345,据此计算出PIA、MIA和IAC的p53-EI预测值分别为4.4%±1.0%、6.8%±1.3%和8.5%±1.4%(Kruskal-Wallis检验P<0.001;Tamhane's T2检验:PIA与MIA比较P<0.001,MIA与IAC比较P<0.001)。虽然差异不显著,但在区分MIA与PIA(曲线下面积[AUC] 0.938对0.914,P = 0.263)以及区分IAC与MIA(AUC 0.812对0.786,P = 0.718)方面,p53-EI预测值的曲线下面积略高于实际值。
通过CT测量获得的nGGO的p53-EI预测值不仅能从影像学角度,还能从病理学角度准确估计病变的病理情况和侵袭性,从而实现术前评估。